Evidence-based decision making and covid-19: what a posteriori probability distributions speak What Posterior Probabilities Reveal
Main Article Content
Abstract
Background: In the absence of any pharmaceutical interventions, the management of the COVID-19 pandemic is based on public health measures. The present study fosters evidence-based decision making by estimating various “a posteriori probability distributions" from COVID-19 patients.
Methods: In this retrospective observational study, 987 RT-PCR positive COVID-19 patients from SMS Medical College, Jaipur, India, were enrolled after approval of the institutional ethics committee. The data regarding age, gender, and outcome were collected. The univariate and bivariate distributions of COVID-19 cases with respect to age, gender, and outcome were estimated. The age distribution of COVID-19 cases was compared with the general population's age distribution using the goodness of fit c2 test. The independence of attributes in bivariate distributions was evaluated using the chi-square test for independence.
Results: The age group ‘25-29’ has shown highest probability of COVID-19 cases (P [25-29] = 0.14, 95% CI: 0.12- 0.16). The men (P [Male] = 0.62, 95%CI: 0.59-0.65) were dominant sufferers. The most common outcome was recovery (P [Recovered] = 0.79, 95%CI: 0.76-0.81) followed by admitted cases (P [Active]= 0.13, 95%CI: 0.11-0.15) and death (P [Death] = 0.08, 95%CI: 0.06-0.10). The age distribution of COVID-19 cases differs significantly from the age distribution of the general population (c2 =399.04, P < 0.001). The bivariate distribution of COVID-19 across age and outcome was not independent (c2 =106.21, df = 32, P < 0.001).
Conclusion: The knowledge of disease frequency patterns helps in the optimum allocation of limited resources and manpower. The study provides information to various epidemiological models for further analysis.
Article Details
Section
How to Cite
References
1. World Health Organization, Coronavirus disease- 2019. Available
from: https://www.who.int/emergencies/diseases/novel-
coronavirus-2019 [Accessed on 18 June 2020].
2. Rodrigues HS. Application of SIR epidemiological model: new
trends. Intern. J Appl Math Inf.2016; 10: 92–97.
3. Singh R, Adhikari R. Age-structured impact of social distancing
on the COVID-19 epidemic in India.2020; arXiv preprint
arXiv:2003.12055.
4. Brownson RC, Gurney JG, Land GH. Evidence-based decision
making in public health. J Public Health Manag
Pract.1999;5(5):86-97. http://dx.doi.org/10.1097/00124784-
199909000-00012.
5. Indrayan A, Malhotra RK. Medical biostatistics. 4th ed. In
relationships: qualitative dependent, CRC Press, Taylor & Francis
Group, Florida, USA. 2018 pp. 180-182.
6. Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less
susceptible to COVID-19? J Microbiol Immunol
Infect.2020;53(3):371-372.
http://dx.doi.org/10.1016/j.jmii.2020.02.011
7. Bhandari S, Shaktawat AS, Tak A, Patel B, Shukla J, Singhal S, et
al. Logistic regression analysis to predict mortality risk in
COVID-19 patients from routine hematologic parameters.
Ibnosina J Med Biomed Sci.2020;12(2):123-9.
8. Census of India 2011, Government of India. Available from:
https://censusindia.gov.in/2011-prov-
results/paper2/data_files/Raj/7-popu-10-19.pdf [Accessed on 19
June 2020].
9. Epidemiology group of the new coronavirus pneumonia
emergency response mechanism of the Chinese center for disease
control and prevention. epidemiological characteristics of the new
coronavirus pneumonia[J/OL]. Chinese Journal of
Epidemiology2020;41 (2020-0217).
http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003
10. JASP Team, JASP version 0.12.2 [Computer software] University
of Amsterdam, Netherlands; Copyright 2013-2019
11. MATLAB Team, Statistics and Machine Learning Toolbox 10.2,
Classification Learner App, MATLAB. version 9.0.0.341360 (R
2016a). Natick, Massachusetts: The MathWorks Inc.
12. Bhandari S, Shaktawat AS, Tak A, Patel B, Gupta K, Gupta J, et
al. A multistate ecological study comparing evolution of
cumulative cases (trends) in top eight COVID-19 hit Indian states
with regression modeling. Int J Acad Med 2020; 6 (2):91-95.
http://dx.doi.org/10.4103/IJAM.IJAM_60_20
13. Adhikari SP, Meng S, Wu Y-J, Mao Y-P, Ye R-X, Wang Q-Z, et
al. Epidemiology, causes, clinical manifestation and diagnosis,
prevention and control of coronavirus disease (COVID-19) during
the early outbreak period: a scoping review. Infectious Diseases of
Poverty 2020;17: 9(1). http://dx.doi.org/10.1186/s40249-020-
00646-x
14. Gandhi PA, Kathirvel S. Epidemiological studies on coronavirus
disease 2019 pandemic in India: Too little and too late? Med J
Armed Forces India. 2020; 76(3): 364–365.
http://dx.doi.org/10.1016/j.mjafi.2020.05.003
15. Kakkar S, Bhandari S, Shaktawat A, Sharma R, Dube A, Banerjee
S, et al. A preliminary clinico-epidemiological portrayal of
COVID-19 pandemic at a premier medical institution of North
India. Annals of Thoracic Medicine2020;15(3):146.
http://dx.doi.org/10.4103/atm.ATM_182_20
16. Times of India. Available from:
https://timesofindia.indiatimes.com/home/education/news/govt-
announces-closure-of-all-educational-establishments-across-india-
till-march-31/articleshow/74659627.cms [Accessed on 19 Jun
2020].
17. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology
of COVID-19 among children in China. Pediatrics2020; 145 (6):
e20200702. https://doi.org/10.1542/peds.2020-0702
18. Ram U, Strohschein L, Gaur K. Gender socialization: differences
between male and female youth in India and associations with
mental health. International Journal of Population Research 2014;
2014:1–11. http://dx.doi.org/10.1155/2014/357145
19. Chowdhury SD, Oommen AM. Epidemiology of COVID-19.
Journal of Digestive Endoscopy2020;11(1):3–7.
http://dx.doi.org/10.1055/s-0040-1712187
20. Rajagopalan, Shruti and Tabarrok, Alexander T., Pandemic Policy
in Developing Countries: Recommendations for India (April 9,
2020). Mercatus Special Edition Policy Brief, Available at SSRN:
https://ssrn.com/abstract=3593011 or
http://dx.doi.org/10.2139/ssrn.3593011
21. Bhandari S, Shaktawat A, Patel B, Dube A, Kakkar S, Tak A,
Gupta J, Rankawat G. The sequel to COVID-19: the antithesis to
life. Journal of Ideas in Health 2020;3(Special1):205-12.